179 related articles for article (PubMed ID: 37945565)
21. The mitochondria-targeting peptide elamipretide diminishes circulating HtrA2 in ST-segment elevation myocardial infarction.
Hortmann M; Robinson S; Mohr M; Mauler M; Stallmann D; Reinöhl J; Duerschmied D; Peter K; Carr J; Gibson CM; Bode C; Ahrens I
Eur Heart J Acute Cardiovasc Care; 2019 Dec; 8(8):695-702. PubMed ID: 28534645
[TBL] [Abstract][Full Text] [Related]
22. Differences in Short- and Long-Term Outcomes Among Older Patients With ST-Elevation Versus Non-ST-Elevation Myocardial Infarction With Angiographically Proven Coronary Artery Disease.
Vora AN; Wang TY; Hellkamp AS; Thomas L; Henry TD; Goyal A; Roe MT
Circ Cardiovasc Qual Outcomes; 2016 Sep; 9(5):513-22. PubMed ID: 27601458
[TBL] [Abstract][Full Text] [Related]
23. Circadian influence on the microbiome improves heart failure outcomes.
Mistry P; Reitz CJ; Khatua TN; Rasouli M; Oliphant K; Young ME; Allen-Vercoe E; Martino TA
J Mol Cell Cardiol; 2020 Dec; 149():54-72. PubMed ID: 32961201
[TBL] [Abstract][Full Text] [Related]
24. Late Outcomes of Patients With Prehospital ST-Segment Elevation and Appropriate Cardiac Catheterization Laboratory Nonactivation.
Faour A; Pahn R; Cherrett C; Gibbs O; Lintern K; Mussap CJ; Rajaratnam R; Leung DY; Taylor DA; Faddy SC; Lo S; Juergens CP; French JK
J Am Heart Assoc; 2022 Jul; 11(13):e025602. PubMed ID: 35766276
[TBL] [Abstract][Full Text] [Related]
25. Metabolomic Profiling in Acute ST-Segment-Elevation Myocardial Infarction Identifies Succinate as an Early Marker of Human Ischemia-Reperfusion Injury.
Kohlhauer M; Dawkins S; Costa ASH; Lee R; Young T; Pell VR; Choudhury RP; Banning AP; Kharbanda RK; ; Saeb-Parsy K; Murphy MP; Frezza C; Krieg T; Channon KM
J Am Heart Assoc; 2018 Apr; 7(8):. PubMed ID: 29626151
[TBL] [Abstract][Full Text] [Related]
26. Long-term Safety and Efficacy of New-Generation Drug-Eluting Stents in Women With Acute Myocardial Infarction: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration.
Giustino G; Harari R; Baber U; Sartori S; Stone GW; Leon MB; Windecker S; Serruys PW; Kastrati A; Von Birgelen C; Kimura T; Stefanini GG; Dangas GD; Wijns W; Steg PG; Morice MC; Camenzind E; Weisz G; Smits PC; Sorrentino S; Sharma M; Farhan S; Faggioni M; Kandzari D; Galatius S; Jeger RV; Valgimigli M; Itchhaporia D; Mehta L; Kim HS; Chieffo A; Mehran R
JAMA Cardiol; 2017 Aug; 2(8):855-862. PubMed ID: 28658478
[TBL] [Abstract][Full Text] [Related]
27. Ketone ester supplementation suppresses cardiac inflammation and improves cardiac energetics in a swine model of acute myocardial infarction.
Yurista SR; Eder RA; Welsh A; Jiang W; Chen S; Foster AN; Mauskapf A; Tang WHW; Hucker WJ; Coll-Font J; Rosenzweig A; Nguyen CT
Metabolism; 2023 Aug; 145():155608. PubMed ID: 37268056
[TBL] [Abstract][Full Text] [Related]
28. Erythrocytes from patients with ST-elevation myocardial infarction induce cardioprotection through the purinergic P2Y
Jiao T; Collado A; Mahdi A; Jurga J; Tengbom J; Saleh N; Verouhis D; Böhm F; Zhou Z; Yang J; Pernow J
Basic Res Cardiol; 2022 Sep; 117(1):46. PubMed ID: 36112326
[TBL] [Abstract][Full Text] [Related]
29. Mineralocorticoid receptor antagonist pre-treatment and early post-treatment to minimize reperfusion injury after ST-elevation myocardial infarction: The MINIMIZE STEMI trial.
Bulluck H; Fröhlich GM; Nicholas JM; Mohdnazri S; Gamma R; Davies J; Sirker A; Mathur A; Blackman D; Garg P; Moon JC; Greenwood JP; Hausenloy DJ
Am Heart J; 2019 May; 211():60-67. PubMed ID: 30893577
[TBL] [Abstract][Full Text] [Related]
30. Mineralocorticoid receptor antagonist pretreatment to MINIMISE reperfusion injury after ST-elevation myocardial infarction (the MINIMISE STEMI Trial): rationale and study design.
Bulluck H; Fröhlich GM; Mohdnazri S; Gamma RA; Davies JR; Clesham GJ; Sayer JW; Aggarwal RK; Tang KH; Kelly PA; Jagathesan R; Kabir A; Robinson NM; Sirker A; Mathur A; Blackman DJ; Ariti C; Krishnamurthy A; White SK; Meier P; Moon JC; Greenwood JP; Hausenloy DJ
Clin Cardiol; 2015 May; 38(5):259-66. PubMed ID: 25990305
[TBL] [Abstract][Full Text] [Related]
31. Pre-hospital pulse glucocorticoid therapy in patients with ST-segment elevation myocardial infarction transferred for primary percutaneous coronary intervention: a randomized controlled trial (PULSE-MI).
Madsen JM; Obling LER; Rytoft L; Folke F; Hassager C; Andersen LB; Vejlstrup N; Bang LE; Engstrøm T; Lønborg JT
Trials; 2023 Dec; 24(1):808. PubMed ID: 38102687
[TBL] [Abstract][Full Text] [Related]
32. Ten-Year Trends in Patient Characteristics, Treatments, and Outcomes in Myocardial Infarction From National Cardiovascular Data Registry Chest Pain-MI Registry.
Gandhi S; Garratt KN; Li S; Wang TY; Bhatt DL; Davis LL; Zeitouni M; Kontos MC
Circ Cardiovasc Qual Outcomes; 2022 Jan; 15(1):e008112. PubMed ID: 35041478
[TBL] [Abstract][Full Text] [Related]
33. The fuel of respiration of rat kidney cortex.
Weidemann MJ; Krebs HA
Biochem J; 1969 Apr; 112(2):149-66. PubMed ID: 5805283
[TBL] [Abstract][Full Text] [Related]
34. Do We Need Potent Intravenous Antiplatelet Inhibition at the Time of Reperfusion During ST-Segment Elevation Myocardial Infarction?
Allencherril J; Alam M; Levine G; Jneid H; Atar D; Kloner RA; Birnbaum Y
J Cardiovasc Pharmacol Ther; 2019 May; 24(3):215-224. PubMed ID: 30563349
[TBL] [Abstract][Full Text] [Related]
35. Cultivable butyrate-producing bacteria of elderly Japanese diagnosed with Alzheimer's disease.
Nguyen TTT; Fujimura Y; Mimura I; Fujii Y; Nguyen NL; Arakawa K; Morita H
J Microbiol; 2018 Oct; 56(10):760-771. PubMed ID: 30136260
[TBL] [Abstract][Full Text] [Related]
36. Effects of Percutaneous Coronary Intervention on Death and Myocardial Infarction Stratified by Stable and Unstable Coronary Artery Disease: A Meta-Analysis of Randomized Controlled Trials.
Chacko L; P Howard J; Rajkumar C; Nowbar AN; Kane C; Mahdi D; Foley M; Shun-Shin M; Cole G; Sen S; Al-Lamee R; Francis DP; Ahmad Y
Circ Cardiovasc Qual Outcomes; 2020 Feb; 13(2):e006363. PubMed ID: 32063040
[TBL] [Abstract][Full Text] [Related]
37. Continuous multi-day tracking of post-myocardial infarction recovery of cardiac electrical stability and autonomic tone using electrocardiogram patch monitors.
Verrier RL; Varma N; Nearing BD
Ann Noninvasive Electrocardiol; 2023 Jan; 28(1):e13035. PubMed ID: 36630149
[TBL] [Abstract][Full Text] [Related]
38. Fibroblast activation protein imaging in reperfused ST-elevation myocardial infarction: comparison with cardiac magnetic resonance imaging.
Xie B; Wang J; Xi XY; Guo X; Chen BX; Li L; Hua C; Zhao S; Su P; Chen M; Yang MF
Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2786-2797. PubMed ID: 34984503
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of gut microbiota-derived metabolites in patients with ST-segment elevation myocardial infarction.
Zhao S; Tian Y; Wang S; Yang F; Xu J; Qin Z; Liu X; Cao M; Zhao P; Zhang G; Wang Z; Zhang Y; Wang Y; Lin K; Fang S; Wang Z; Han T; Tian M; Yin H; Tian J; Yu B
Am J Clin Nutr; 2023 Mar; 117(3):499-508. PubMed ID: 36811471
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of p38 MAP kinase in patients with ST-elevation myocardial infarction - findings from the LATITUDE-TIMI 60 trial.
Cavender MA; O'Donoghue ML; Abbate A; Aylward P; Fox KA; Glaser RX; Park JG; Lopez-Sendon J; Steg PG; Sabatine MS; Morrow DA
Am Heart J; 2022 Jan; 243():147-157. PubMed ID: 34508693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
